Janus Kinase 2, antagonists & inhibitors

Name
Janus Kinase 2, antagonists & inhibitors
Accession Number
DBCAT002779
Description

Not Available

Drugs
DrugDrug Description
PacritinibA kinase inhibitor used for the treatment of primary and secondary myelofibrosis in adult patients with significantly reduced platelet counts.
AZD-1480AZD1480 has been used in trials studying the treatment of Solid Malignancies, Post-Polycythaemia Vera, Primary Myelofibrosis (PMF), and Essential Thrombocythaemia Myelofibrosis.
BMS-911543BMS-911543 has been used in trials studying the treatment of Cancer.
GandotinibGandotinib has been used in trials studying the treatment of Myelofibrosis, Polycythemia Vera, Primary Myelofibrosis, Thrombocythemia, Essential, and Myeloproliferative Disorders, among others.
Drugs & Drug Targets
DrugTargetType
PacritinibCytochrome P450 3A4enzyme
PacritinibCytochrome P450 1A2enzyme
PacritinibTyrosine-protein kinase JAK2target
PacritinibReceptor-type tyrosine-protein kinase FLT3target
PacritinibP-glycoprotein 1transporter
PacritinibATP-binding cassette sub-family G member 2transporter
PacritinibSolute carrier family 22 member 1transporter
PacritinibCytochrome P450 2C19enzyme
PacritinibSolute carrier family 22 member 2transporter